UNSPSC 51411610: Tipropidil

This classification denotes a vasodilating agent with the molecular formula C20H35NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 007QF56M4D, chemically known as 2-propanol, 1-(4-((1-methylethyl)thio)phenoxy)-3-(octylamino)- but generally known as tipropidil, which bears US NIH Compound Identifier 72176. European Medicines Agency schedules Tipropidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11108MIG.

UNSPSC 51411610 Tipropidil is a Commodity code that captures specialty pharmaceuticals for emergency medical and state healthcare systems, based on recent state and local procurement activity showing demand for advanced life support medications and generic multi-source pharmaceutical supply contracts. State and local governments soliciting under this code include emergency service departments (fire rescue), state health and human services agencies, and multi-state cooperative purchasing alliances. The work involves supplying regulated pharmaceutical products—injectable medications for emergency response, generic pharmaceuticals for institutional distribution, and over-the-counter products for healthcare facilities—with strict compliance requirements including FDA registration, cGMP certification, Drug Supply Chain Security Act (DSCSA) compliance, Safety Data Sheets, and minimum shelf-life guarantees. Vendors must meet expiration-date standards (typically nine months to one year minimum from acceptance), arrange delivery or pickup within specified windows, and warrant product quality. Contracts frequently run one to two years with renewal or extension options, and issuing bodies reserve the right to make single, dual, or multiple awards based on therapeutic need and product availability.

Recent activity appears concentrated in Texas, Minnesota, and Florida. The City of Tampa's Purchasing Department posted IFB 26P00188 on April 24, 2026 (due April 8, 2026) seeking advanced life support medications—Labetalol HCI, Epinephrine 1:10,000, Adenosine, and Diltiazem—for Tampa Fire Rescue with a one-year contract term and estimated value of $40,000; the solicitation included a 5 percent Small Local Business Enterprise bid discount. The Minnesota Department of Administration, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with evaluation weighted 75 percent on price competitiveness and effective date July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling future formal procurement to improve prescription fulfillment outside traditional pharmacy benefit manager and group purchasing organization channels.